Omnitrope and Cognitive disorder - a phase IV clinical study of FDA data

Summary:

Cognitive disorder is reported as a side effect among people who take Omnitrope (somatropin recombinant), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin C, and have Cataplexy.

The phase IV clinical study analyzes which people have Cognitive disorder when taking Omnitrope. It is created by eHealthMe based on reports of 8,562 people who have side effects when taking Omnitrope from the FDA, and is updated regularly.

What is Omnitrope?

Omnitrope has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 8,582 Omnitrope users. Check the latest studies of Omnitrope.

What is Cognitive disorder?

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving) is found to be associated with 1,649 drugs and 1,727 conditions by eHealthMe. Check the latest studies of Cognitive disorder.

On Aug, 04, 2026

8,562 people reported to have side effects when taking Omnitrope.
Among them, 24 people (0.28%) have Cognitive disorder.

Could Omnitrope cause Cognitive disorder?

Among these 24 people:

How long have people been on Omnitrope when they have Cognitive disorder? *

What is the gender of people who have Cognitive disorder when taking Omnitrope? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Cognitive disorder when taking Omnitrope? *

What are other drugs people take besides Omnitrope? *

What are other side effects people have besides Cognitive disorder? *

Memory Loss: 6 people, 25.00%
Fatigue (feeling of tiredness): 4 people, 16.67%
Speech Disorder: 4 people, 16.67%
Dementia (madness): 4 people, 16.67%
Crying: 4 people, 16.67%
Gait Disturbance: 3 people, 12.50%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 12.50%
Confusional State: 3 people, 12.50%
Communication Disorder (speech and language disorder): 2 people, 8.33%
Drowsiness: 2 people, 8.33%

What are the existing conditions these people have? *

Sleep Disorder: 2 people, 8.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.33%
High Blood Pressure: 2 people, 8.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 8.33%
Sinus Congestion (blockage of sinus): 1 person, 4.17%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 1 person, 4.17%
Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 4.17%
High Blood Cholesterol: 1 person, 4.17%
Haematoma (collection of blood outside the blood vessels): 1 person, 4.17%
Gout (uric acid crystals building up in the body): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Omnitrope and have Cognitive disorder?

- Check whether Cognitive disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omnitrope:

Omnitrope (8,582 reports)

Browse all side effects of Omnitrope:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cognitive disorder:

Cognitive disorder (1,649 drugs)

Browse all the conditions that are associated with Cognitive disorder:

Cognitive disorder (1,727 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Omnitrope) and Omnitrope (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.